BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Dupixent Discussions - ECPv6.15.19//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.dupixentdiscussions.com
X-WR-CALDESC:Events for Dupixent Discussions
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Denver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20240310T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20241103T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20250309T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20251102T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20260308T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20261101T080000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20260308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20261101T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Denver:20251106T121500
DTEND;TZID=America/Denver:20251106T131500
DTSTAMP:20260408T130259
CREATED:20250829T203319Z
LAST-MODIFIED:20250919T211716Z
UID:10000742-1762431300-1762434900@www.dupixentdiscussions.com
SUMMARY:Pearls and Common Challenges for the Diagnosis of Bullous Pemphigoid (BP) by Daniel Butler\, MD
DESCRIPTION:Learn more about the diagnosis and assessment of bullous pemphigoid (BP) including clinical manifestations\, key\nlaboratory investigations for diagnostic evaluation\, consensus-based recommendations and a treatment option for appropriate BP patients[gravityform id=”1″ field_values=”zoomid=98116325780″]
URL:https://www.dupixentdiscussions.com/event/pearls-and-common-challenges-for-the-diagnosis-of-bullous-pemphigoid-bp-by-daniel-butler-md/
LOCATION:Virtual (Zoom)
CATEGORIES:Bullous Pemphigoid (BP)
ATTACH;FMTTYPE=image/png:https://www.dupixentdiscussions.com/wp-content/uploads/2025/06/Daniel-Butler-MD.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251029T121500
DTEND;TZID=America/New_York:20251029T124500
DTSTAMP:20260408T130259
CREATED:20250829T203314Z
LAST-MODIFIED:20250926T005413Z
UID:10000733-1761740100-1761741900@www.dupixentdiscussions.com
SUMMARY:A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation by Douglas DiRuggiero\, PA-C
DESCRIPTION:This program is being held in partnership with SDPA. Please visit the link below to be taken to the registration page for this program. \nRegister \n 
URL:https://www.dupixentdiscussions.com/event/a-treatment-option-for-appropriate-patients-with-skin-diseases-driven-in-part-by-type-2-inflammation-by-douglas-diruggiero-pa-c/
LOCATION:Virtual (Zoom)
CATEGORIES:Bullous Pemphigoid (BP)
ATTACH;FMTTYPE=image/png:https://www.dupixentdiscussions.com/wp-content/uploads/2025/05/Douglas-DiRuggiero-PA-C.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20251027T121500
DTEND;TZID=America/Chicago:20251027T131500
DTSTAMP:20260408T130259
CREATED:20250829T203312Z
LAST-MODIFIED:20260206T162535Z
UID:10000731-1761567300-1761570900@www.dupixentdiscussions.com
SUMMARY:Pearls and Common Challenges for the Diagnosis of Bullous Pemphigoid (BP) by Timothy Patton\, DO
DESCRIPTION:Learn more about the diagnosis and assessment of bullous pemphigoid (BP) including clinical manifestations\, key\nlaboratory investigations for diagnostic evaluation\, consensus-based recommendations and a treatment option for appropriate BP patients
URL:https://www.dupixentdiscussions.com/event/pearls-and-common-challenges-for-the-diagnosis-of-bullous-pemphigoid-bp-by-timothy-patton-dp/
LOCATION:Virtual (Zoom)
CATEGORIES:Bullous Pemphigoid (BP)
ATTACH;FMTTYPE=image/png:https://www.dupixentdiscussions.com/wp-content/uploads/2025/06/Timothy-Patton-DO.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20251015T121500
DTEND;TZID=America/Los_Angeles:20251015T131500
DTSTAMP:20260408T130259
CREATED:20250829T203308Z
LAST-MODIFIED:20250919T211311Z
UID:10000723-1760530500-1760534100@www.dupixentdiscussions.com
SUMMARY:Pearls and Common Challenges for the Diagnosis of Bullous Pemphigoid (BP)  by Matthew Lewis\, MD
DESCRIPTION:Learn more about the diagnosis and assessment of bullous pemphigoid (BP) including clinical manifestations\, key\nlaboratory investigations for diagnostic evaluation\, consensus-based recommendations and a treatment option for appropriate BP patients[gravityform id=”1″ field_values=”zoomid=91473816744″]
URL:https://www.dupixentdiscussions.com/event/pearls-and-common-challenges-for-the-diagnosis-of-bullous-pemphigoid-bp-by-matthew-lewis-md/
LOCATION:Virtual (Zoom)
CATEGORIES:Bullous Pemphigoid (BP)
ATTACH;FMTTYPE=image/png:https://www.dupixentdiscussions.com/wp-content/uploads/2025/06/Matthew-Lewis-MD.png
END:VEVENT
END:VCALENDAR